![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/03/2892562/0/en/Celcuity-To-Participate-in-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/30/2890595/0/en/Celcuity-Inc-Announces-Plan-to-Initiate-a-Phase-3-Clinical-Trial-for-Gedatolisib-as-First-Line-Treatment-for-HR-HER2-Advanced-Breast-Cancer-and-Secures-Approximately-62-Million-Deb.html
https://www.globenewswire.com/news-release/2024/05/30/2890658/0/en/Celcuity-Announces-Pricing-of-Underwritten-Common-Stock-Offering.html
https://www.globenewswire.com/news-release/2024/05/15/2882852/0/en/Celcuity-Inc-Reports-First-Quarter-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/08/2877694/0/en/Celcuity-Inc-Schedules-Release-of-First-Quarter-2024-Financial-Results-and-Webcast-Conference-Call.html
https://www.globenewswire.com/news-release/2024/04/04/2857655/0/en/Celcuity-To-Present-at-Upcoming-Needham-and-Stifel-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/03/27/2853589/0/en/Celcuity-Inc-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/03/20/2849240/0/en/Celcuity-Inc-Schedules-Release-of-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Webcast-Conference-Call.html
https://www.globenewswire.com//news-release/2024/03/06/2841271/0/en/Celcuity-to-Participate-in-Leerink-Partners-Global-Biopharma-Conference-2024.html
https://www.globenewswire.com//news-release/2024/02/28/2836824/0/en/Celcuity-to-Participate-in-Cowen-s-44th-Annual-Health-Care-Conference.html